Derek Hicks Intellia Therapeutics, Inc. (NTLA) insider trading activity
Derek Hicks is EVP, Chief Business Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 66,380 shares of NTLA, which is worth approximately $943,923. The most recent transaction as insider was on Mar 01, 2024, when has been sold 29,393 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
66.4K
0%
3M change
62.44%
12M change
Total Value Held
$943,923
Derek Hicks Transaction History
DH
Derek Hicks
EVP, Chief Business Officer
Cambridge, MA